2023年10月23日 · In our bariatric unit, we prescribe UDCA (650 mg) during the rapid weight-loss period that occurs over the first 6 months after surgery. In conclusion, the use of UDCA in …

Promising regimens are high doses of ursodeoxycholic acid (UDCA) alone or in combination with other drugs, and tacrolimus (FK506). Presently, liver transplantation is the only definitive …

2023年3月23日 · Ursodeoxycholic acid (UDCA) is a bile acid that dissolves gallstones. There is increasing interest in UDCA for symptomatic gallstones, particularly in those unfit for surgery. …

2023年2月12日 · Ursodeoxycholic acid is a medication used to manage and treat cholestatic liver disease. This activity reviews the indications, mechanism of action, and contraindications for …

Ursodeoxycholic acid (Ursodeoxycholate) 是由肠道细菌转化 (cheno) 脱氧胆酸而产生的一种次级胆汁酸，是肠道屏障完整性的关键调节因子，对脂质代谢至关重要。 Ursodeoxycholic acid 作 …

UDCA能够减少胆固醇向胆汁的分泌，与胆固醇分子形成混合胶束（液晶）并与多功能核受体相互作用，被积极用于治疗和预防胆石症。 UDCA具有刺激肝胆分泌的能力，促进胆管细胞分泌碳 …

2020年7月9日 · 熊去氧胆酸 (udca)是一种用于胆汁淤积性肝病治疗的重要药物。udca 作为内源性药物的代表，在人体内具有胆汁酸特有的宿主-肠道菌群共代谢和肝-胆-肠循环处置特征，这为 …

熊脱氧胆酸(ursodeoxycholic acid，UDCA)：它是双羟基胆汁酸，亲水性，在急性和慢性肝炎的应用正在扩大。 胆盐促使水份、卵磷脂、胆固醇和结合胆红素从胆道排泄，熊脱氧胆酸盐比其 …

2021年10月26日 · The role of ursodeoxycholic acid (UDCA) in cholelithiasis management after one anastomosis gastric bypass (OAGB) for morbid obesity: results of a monocentric …

View ursodeoxycholic acid information, including dose, uses, side-effects, pregnancy, breast feeding, contra-indications and monitoring requirements.